A recent study from Ontario, Canada, has revealed that Bavarian Nordic A/S’s smallpox vaccine, marketed as Imvamune in Canada and Jynneos in the US, was 58% effective in preventing mpox infections after a single dose.
Trending
- AKK gas pipeline 95% complete, on track for commissioning
- Tinubu inaugurates remodelled Abuja city gate
- Birds devastate Bakalori farms, Zamfara farmers seek urgent help
- Zamfara approves 6 month maternity leave for female civil servants
- Anambra woman delivers triplets free under maternal healthcare scheme
- Kaduna unveils 2026–2030 family planning plan
- FGN/IFAD promotes agriculture in Anambra schools
- Nigeria launches Ebola response plan
